P2.01-04 NCI-NRG Oncology ALK PROTOCOL (NRG-LU003): A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients
JOURNAL OF THORACIC ONCOLOGY（2019）
关键词
ALK Resistance mutation Trial,liquid biopsy,advanced ALK Positive Lung Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要